Featured Research

from universities, journals, and other organizations

Americans Pay The Most For Prescription Drugs And Still Don't Take Them

Date:
January 9, 2008
Source:
University of Michigan
Summary:
An international study of dialysis patients shows that although US residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries.

An international study of dialysis patients shows that although U.S. residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries.

The new research from the University of Michigan School of Public Health and the Arbor Research Collaborative for Health found that high out-of-pocket drug costs are only a partial reason why fewer American dialysis patients took their medications than in other countries, said Richard Hirth, professor at the U-M School of Public Health.

"There is something about Americans that make them more noncompliant with their drugs even when you leave out the higher cost of the drugs," said Hirth, who co-authored the paper with Scott Greer, assistant professor at the School of Public Health. "The study looked at drug costs and adherence in hemodialysis patients from 12 developed countries participating in the Dialysis Outcomes and Practice Patterns Study.

Dialysis patients in the United Kingdom enjoyed the lowest out-of-pocket spending, at $8 per month, compared to $114 per month in the United States. The percentage of people who did not adhere to their drug regimens because of cost ranged from 3 percent in Japan to 29 percent in the United States—a percentage higher than expected, even accounting for the high cost of U.S. prescriptions, Hirth said.

Hirth and Greer simulated the impact of prescription drug coverage under Medicare Part D, implemented after the survey, and determined that U.S. out-of-pocket burdens would remain high by international standards, though no longer the highest, with the projected U.S. burden falling below that of Swedish patients. Nonetheless, they projected that although non-adherence would decline after the implementation of Part D, it would still remain well above that in any other country in the sample. Thus, the high non-adherence rate in the United States is only partially explained by high out-of-pocket costs, Hirth said.

So, the researchers examined features of health policy across these 12 countries that might modify the relationship between out-of-pocket costs and non-adherence. There is some suggestion in the data that, in addition to modifying the absolute out-of-pocket burden, policies that craft exemptions from co-payments for targeted subpopulations may be particularly effective at reducing non-adherence.

Dialysis patients are the perfect study population because the condition and the treatment—kidney failure and dialysis—are similar everywhere, Hirth said. Prior research on drug adherence has almost always focused on data from a single country or has been based on different data sources across countries, obscuring the contributions of policy to any observed differences.

A recent survey showed that drug prices in the United States are 6 percent to 33 percent higher than in other industrialized countries, with only Japan having higher prices. There are two ways to control drug costs: regulate the price directly or via negotiation, and set the mechanism for how people pay, such as a co-pay or flat fee, and how you define who has to pay.

"Since we don't control the costs directly, we rely very heavily on out-of-pocket costs," Greer said. "If you can't control prices, you need to control the co-pays."

The paper, "Out-of-pocket spending and medication adherence among dialysis patients in 12 countries" will appear in the journal Health Affairs on Jan. 8.

Other co-authors on the paper include: Justin Albert, research analyst at Arbor Research Collaborative for Health; Eric Young, assistant dean, Veterans Affairs Ann Arbor Healthcare System, and John Piette, associate professor, Department of Internal Medicine, U-M.


Story Source:

The above story is based on materials provided by University of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan. "Americans Pay The Most For Prescription Drugs And Still Don't Take Them." ScienceDaily. ScienceDaily, 9 January 2008. <www.sciencedaily.com/releases/2008/01/080108150432.htm>.
University of Michigan. (2008, January 9). Americans Pay The Most For Prescription Drugs And Still Don't Take Them. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2008/01/080108150432.htm
University of Michigan. "Americans Pay The Most For Prescription Drugs And Still Don't Take Them." ScienceDaily. www.sciencedaily.com/releases/2008/01/080108150432.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins